This is a Validated Antibody Database (VAD) review about rat Bcl2l11, based on 86 published articles (read how Labome selects the articles), using Bcl2l11 antibody in all methods. It is aimed to help Labome visitors find the most suited Bcl2l11 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Bcl2l11 synonym: Bim; BimL; Bod

Knockout validation
Cell Signaling Technology
domestic rabbit monoclonal (C34C5)
  • western blot knockout validation; human; 1:1000; loading ...; fig 5h, 5i
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot knockout validation on human samples at 1:1000 (fig 5h, 5i). Nat Commun (2020) ncbi
Abcam
domestic rabbit monoclonal (Y36)
  • western blot; human; loading ...; fig 4e
Abcam Bcl2l11 antibody (Abcam, ab32158) was used in western blot on human samples (fig 4e). elife (2019) ncbi
domestic rabbit monoclonal (Y36)
  • western blot; human; 1:1000; loading ...; fig 5b
Abcam Bcl2l11 antibody (Abcam, ab32158) was used in western blot on human samples at 1:1000 (fig 5b). Front Neurosci (2019) ncbi
domestic rabbit monoclonal (Y36)
  • western blot; human; 1:2000; loading ...; fig 4b
Abcam Bcl2l11 antibody (Abcam, ab32158) was used in western blot on human samples at 1:2000 (fig 4b). Biosci Rep (2018) ncbi
domestic rabbit monoclonal (Y36)
  • other; human; loading ...; fig 4c
Abcam Bcl2l11 antibody (Abcam, ab32158) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (Y36)
  • western blot; human; loading ...; fig 4
Abcam Bcl2l11 antibody (Abcam, ab32158) was used in western blot on human samples (fig 4). Braz J Med Biol Res (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
Abcam Bcl2l11 antibody (Abcam, ab15184) was used in western blot on human samples (fig 5a). PLoS Med (2016) ncbi
domestic rabbit monoclonal (Y36)
  • western blot; human; fig 2
Abcam Bcl2l11 antibody (Abcam, 32158) was used in western blot on human samples (fig 2). BMC Cancer (2016) ncbi
domestic rabbit monoclonal (Y36)
  • western blot; rat; 1:200; loading ...; fig 5
Abcam Bcl2l11 antibody (Abcam, ab32158) was used in western blot on rat samples at 1:200 (fig 5). Exp Ther Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3g
Abcam Bcl2l11 antibody (Abcam, ab7888) was used in western blot on human samples at 1:1000 (fig 3g). Am J Physiol Lung Cell Mol Physiol (2016) ncbi
domestic rabbit monoclonal (Y36)
  • western blot; human; fig 1
Abcam Bcl2l11 antibody (Abcam, ab32158) was used in western blot on human samples (fig 1). Neoplasia (2013) ncbi
Santa Cruz Biotechnology
mouse monoclonal (H-5)
  • western blot; human; loading ...; fig 6d
Santa Cruz Biotechnology Bcl2l11 antibody (Santa Cruz Biotechnology, H-5) was used in western blot on human samples (fig 6d). Sci Adv (2020) ncbi
mouse monoclonal (H-5)
  • western blot; human; 1:500; loading ...; fig 6a
Santa Cruz Biotechnology Bcl2l11 antibody (Santa Cruz, sc-374358) was used in western blot on human samples at 1:500 (fig 6a). PLoS ONE (2017) ncbi
MilliporeSigma
domestic rabbit polyclonal
  • western blot; human; fig 4
MilliporeSigma Bcl2l11 antibody (Sigma-Aldrich, B7929) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
StressMarq Biosciences
domestic rabbit polyclonal
  • western blot; human; fig 4c
In order to evaluate the use of a pan-PI3K inhibitor in chronic lymphocytic leukemia patients, StressMarq Biosciences Bcl2l11 antibody (Stressmarq, SPC-113D) was used in western blot on human samples (fig 4c). Leukemia (2016) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling Technology, 2933) was used in western blot on human samples at 1:1000 (fig 1a). elife (2020) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; fig 2n
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 2n). Cell Death Differ (2020) ncbi
domestic rabbit monoclonal (D7E11)
  • western blot; human
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 4585) was used in western blot on human samples . Cell Death Differ (2020) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot knockout validation; human; 1:1000; loading ...; fig 5h, 5i
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot knockout validation on human samples at 1:1000 (fig 5h, 5i). Nat Commun (2020) ncbi
domestic rabbit monoclonal (C34C5)
  • flow cytometry; mouse
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling Technology, C34C5) was used in flow cytometry on mouse samples . Nature (2019) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; 1:500; fig 4a
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling Technology, 2933) was used in western blot on human samples at 1:500 (fig 4a). elife (2019) ncbi
domestic rabbit monoclonal (C34C5)
  • flow cytometry; mouse; loading ...; fig s2d
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 12186) was used in flow cytometry on mouse samples (fig s2d). Cell Rep (2019) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; loading ...; fig 6c
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples at 1:1000 (fig 6c). Oncogene (2019) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 4f
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 4f). J Clin Invest (2019) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; mouse; loading ...; fig s3i
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on mouse samples (fig s3i). Science (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5c
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling Technology, 2819) was used in western blot on human samples (fig 5c). Blood Cancer J (2019) ncbi
domestic rabbit monoclonal (C34C5)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6b
  • immunohistochemistry - paraffin section; human; loading ...; fig 3e
Cell Signaling Technology Bcl2l11 antibody (CST, 2933) was used in immunohistochemistry - paraffin section on mouse samples (fig 6b) and in immunohistochemistry - paraffin section on human samples (fig 3e). Nat Commun (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s2b
Cell Signaling Technology Bcl2l11 antibody (CST, 2819) was used in western blot on human samples (fig s2b). Nat Commun (2019) ncbi
domestic rabbit monoclonal (C34C5)
  • immunohistochemistry; mouse; 1:400; loading ...; fig 1a
  • western blot; mouse; 1:1000; loading ...; fig 1e
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in immunohistochemistry on mouse samples at 1:400 (fig 1a) and in western blot on mouse samples at 1:1000 (fig 1e). Neuroscience (2019) ncbi
domestic rabbit monoclonal (C34C5)
  • flow cytometry; mouse; loading ...; fig 3b
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, C34C5) was used in flow cytometry on mouse samples (fig 3b). J Immunol (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2819) was used in western blot on human samples (fig 3a). Oncotarget (2017) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; loading ...; fig s4a
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples at 1:1000 (fig s4a). Nat Med (2017) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling Technology, 2933) was used in western blot on human samples (fig 4c). Nat Med (2017) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling Technology, 2933) was used in western blot on human samples (fig 4c). Anticancer Res (2017) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; mouse; 1:1000; loading ...; fig 2c
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, C34C5) was used in western blot on mouse samples at 1:1000 (fig 2c). Nat Commun (2017) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; loading ...; fig 8b
Cell Signaling Technology Bcl2l11 antibody (cell signalling, 2933) was used in western blot on human samples at 1:1000 (fig 8b). Int J Oncol (2017) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig s4k
Cell Signaling Technology Bcl2l11 antibody (Cell signaling, 2933) was used in western blot on human samples (fig s4k). EMBO J (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a
In order to observe that chronic presence of internalized Escherichia coli leads to enhanced oncogenicity in colon cancer cells, Cell Signaling Technology Bcl2l11 antibody (cell signalling, 2819) was used in western blot on human samples (fig 1a). Cell Death Dis (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100; loading ...
  • western blot; human; loading ...; fig 4d
Cell Signaling Technology Bcl2l11 antibody (CST, 2819) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in western blot on human samples (fig 4d). Mol Ther (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6c
In order to find a Cdk5-Foxo1-Bim pathway in cell death in tumorspheres, implicating Cdk5 as a target for tumor-initiating cells, Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2819) was used in western blot on human samples (fig 6c). Br J Cancer (2017) ncbi
domestic rabbit monoclonal (C34C5)
  • flow cytometry; mouse; fig 6j
In order to investigate the mechanisms by which eomesodermin regulates memory fitness in T cells, Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, C34C5) was used in flow cytometry on mouse samples (fig 6j). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit monoclonal (C34C5)
  • flow cytometry; mouse; loading ...; fig 3a
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, C34C5) was used in flow cytometry on mouse samples (fig 3a). J Exp Med (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Bcl2l11 antibody (cell signalling, 4550) was used in western blot on human samples (fig 5a). PLoS Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Bcl2l11 antibody (cell signalling, 4581) was used in western blot on human samples (fig 5a). PLoS Med (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 2b
In order to explore the role of chaperone-mediated autophagy in non-small-cell lung cancer, Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, C34C5) was used in western blot on human samples (fig 2b). Biochem Biophys Res Commun (2017) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig s8d
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig s8d). Nature (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933S) was used in western blot on human samples (fig 4b). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5a
In order to elucidate the upstream mechanisms of apoptosis triggered by an anti-microtubule drug, ABT-751, Cell Signaling Technology Bcl2l11 antibody (cell signalling, 2819) was used in western blot on human samples at 1:1000 (fig 5a). Toxicol Appl Pharmacol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5f
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2819) was used in western blot on human samples (fig 5f). Cancer Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1e
Cell Signaling Technology Bcl2l11 antibody (cell signalling, 2819) was used in western blot on human samples at 1:1000 (fig 1e). Oncotarget (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 4
Cell Signaling Technology Bcl2l11 antibody (Cell signaling, 2933) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • flow cytometry; mouse; loading ...; fig s2b
In order to demonstrate that DNMT3a directs early CD8 positive T-cell effector and memory fate decisions, Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, C34C5) was used in flow cytometry on mouse samples (fig s2b). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 5b,5c,6b,6c,6d
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 5b,5c,6b,6c,6d). Oncotarget (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 1c). Oncotarget (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • flow cytometry; mouse; 1:200
  • western blot; mouse; 1:1000; fig 3
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in flow cytometry on mouse samples at 1:200 and in western blot on mouse samples at 1:1000 (fig 3). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2819) was used in western blot on human samples . elife (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling Tech, 2933S) was used in western blot on human samples at 1:1000 (fig 5). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • flow cytometry; human; loading ...; fig 6
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, Cell Signaling Technology Bcl2l11 antibody (cell signalling, C34C5) was used in flow cytometry on human samples (fig 6). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; fig 3
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 3). Cancer Cell Int (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2819) was used in western blot on human samples (fig 4a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:2000; fig s1b
  • western blot; mouse; 1:2000; fig s1b
  • western blot; human; 1:2000; loading ...; fig s1c
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2819) was used in immunohistochemistry on mouse samples at 1:2000 (fig s1b), in western blot on mouse samples at 1:2000 (fig s1b) and in western blot on human samples at 1:2000 (fig s1c). Cell Death Differ (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 1c
In order to elucidate the mechanism of cisplatin-induced non-small-cell lung cancer cell apoptosis, Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, C34C5) was used in western blot on human samples (fig 1c). Biochem Biophys Res Commun (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; mouse; 1:1000; fig 1e
In order to evaluate the antitumor activity of the pan-HDAC inhibitor, panobinostat, in mice, Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on mouse samples at 1:1000 (fig 1e). Int J Cancer (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; fig 1
In order to investigate the effect of Obatoclax in esophageal cancer cells, Cell Signaling Technology Bcl2l11 antibody (Cell Signaling Tech, 2933) was used in western blot on human samples at 1:1000 (fig 1). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s6
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling Tech, 2819S) was used in western blot on human samples (fig s6). Sci Signal (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
In order to learn how oncogene addiction can be broken in tumors with MET amplification by the Anti-c-Met monoclonal antibody ABT-700, Cell Signaling Technology Bcl2l11 antibody (Cell signaling, 2819) was used in western blot on human samples (fig 2). BMC Cancer (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • flow cytometry; mouse
In order to examine the contribution of Foxo1 to activated T cells, Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, C34C5) was used in flow cytometry on mouse samples . Nature (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; fig 6
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; fig 6
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 6). Front Genet (2015) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; fig 4
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933S) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 1
In order to study the effects of HDAC inhibitors and BCL-2 inhibitors on small cell lung cancer lines, Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, C34C5) was used in western blot on human samples (fig 1). Cancer Biol Ther (2016) ncbi
domestic rabbit monoclonal (D7E11)
  • immunohistochemistry; mouse; 1:400; loading ...; fig s6a
In order to evaluate the use of phenformin with MLN0128 as a treatment strategy for non-small cell lung carcinoma, Cell Signaling Technology Bcl2l11 antibody (Cell signaling, 4585) was used in immunohistochemistry on mouse samples at 1:400 (fig s6a). Cancer Res (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2d
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2819) was used in western blot on human samples at 1:1000 (fig 2d). Oncotarget (2016) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 7b
  • western blot; mouse; loading ...; fig s8
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 7b) and in western blot on mouse samples (fig s8). Oncotarget (2015) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; fig 2
In order to identify the mechanism for apoptosis in colon cancer cells after depletion of PTEN, Cell Signaling Technology Bcl2l11 antibody (Cell Signaling Technology, 2933) was used in western blot on human samples at 1:1000 (fig 2). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (C34C5)
  • immunohistochemistry - paraffin section; human
Cell Signaling Technology Bcl2l11 antibody (CST, 2933) was used in immunohistochemistry - paraffin section on human samples . Nature (2015) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 6b
Cell Signaling Technology Bcl2l11 antibody (Cell signaling, 2933) was used in western blot on human samples (fig 6b). Oncotarget (2015) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; fig 3
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling Tech, C34C5) was used in western blot on human samples (fig 3). Oncotarget (2015) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; 1:5000; fig 4
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples at 1:5000 (fig 4). Infect Immun (2015) ncbi
domestic rabbit monoclonal (C34C5)
  • immunohistochemistry - paraffin section; dogs
  • western blot; dogs
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, C34C5) was used in immunohistochemistry - paraffin section on dogs samples and in western blot on dogs samples . Int J Oncol (2015) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; fig 8
In order to analyze thyroid hormone receptor beta for oncogenic mutations, Cell Signaling Technology Bcl2l11 antibody (Cell Signaling Technology, 2933) was used in western blot on human samples at 1:1000 (fig 8). Oncotarget (2015) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; fig 2
Cell Signaling Technology Bcl2l11 antibody (Cell signaling, 2933) was used in western blot on human samples (fig 2). Pigment Cell Melanoma Res (2015) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human
In order to study the mechanism for the metastasis of ErbB2-positive breast cancer cells, Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples . J Biol Chem (2015) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; fig 5
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 5). Biomed Res Int (2015) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; fig 3
In order to assess the efficacy of alisertib against glioblastoma neurosphere tumor stem-like cells in vitro and in vivo, Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples at 1:1000 (fig 3). Cancer Res (2014) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; mouse; 1:1000; fig 6
In order to investigate whether drugs that increase Hsp70/Hsp110 levels protect cells from traumatic brain injury, Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on mouse samples at 1:1000 (fig 6). J Neurochem (2014) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human
In order to evaluate the effect of Noxa on the localization and stability of MCL-1 in small cell lung cancer, Cell Signaling Technology Bcl2l11 antibody (Cell Signaling Technology, C34C5) was used in western blot on human samples . Cell Death Dis (2014) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, 2933) was used in western blot on human samples . Cell Death Dis (2014) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; mouse
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling Technology, 2933) was used in western blot on mouse samples . J Neurosci (2013) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; human; 1:1000
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling Technologies, C34C5) was used in western blot on human samples at 1:1000. Cell Death Differ (2013) ncbi
domestic rabbit monoclonal (C34C5)
  • western blot; mouse
Cell Signaling Technology Bcl2l11 antibody (Cell Signaling, C34C5) was used in western blot on mouse samples . Mol Cancer Ther (2013) ncbi
Articles Reviewed
  1. Arai S, Varkaris A, Nouri M, Chen S, Xie L, Balk S. MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation. elife. 2020;9: pubmed publisher
  2. Simula L, Corrado M, Accordi B, Di Rita A, Nazio F, Antonucci Y, et al. JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD induction. Cell Death Differ. 2020;: pubmed publisher
  3. Bajpai R, Sharma A, Achreja A, Edgar C, Wei C, Siddiqa A, et al. Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma. Nat Commun. 2020;11:1228 pubmed publisher
  4. Aldonza M, Ku J, Hong J, Kim D, Yu S, Lee M, et al. Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms. Sci Adv. 2020;6:eaav7416 pubmed publisher
  5. Wei J, Long L, Zheng W, Dhungana Y, Lim S, Guy C, et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature. 2019;576:471-476 pubmed publisher
  6. Hagenbuchner J, Obsilova V, Kaserer T, Kaiser N, Rass B, Psenakova K, et al. Modulating FOXO3 transcriptional activity by small, DBD-binding molecules. elife. 2019;8: pubmed publisher
  7. Wang L, Shen E, Luo L, Rabe H, Wang Q, Yin J, et al. Control of Germinal Center Localization and Lineage Stability of Follicular Regulatory T Cells by the Blimp1 Transcription Factor. Cell Rep. 2019;29:1848-1861.e6 pubmed publisher
  8. Kabir S, Cidado J, Andersen C, Dick C, Lin P, Mitros T, et al. The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells. elife. 2019;8: pubmed publisher
  9. Sun B, Zhao X, Ming J, Liu X, Liu D, Jiang C. Stepwise detection and evaluation reveal miR-10b and miR-222 as a remarkable prognostic pair for glioblastoma. Oncogene. 2019;38:6142-6157 pubmed publisher
  10. Pan C, Jin L, Wang X, Li Y, Chun J, Boese A, et al. Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance. J Clin Invest. 2019;129:2431-2445 pubmed publisher
  11. He M, Chaurushiya M, Webster J, Kummerfeld S, Reja R, Chaudhuri S, et al. Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1. Science. 2019;364:283-285 pubmed publisher
  12. Dong H, Ye X, Zhong L, Xu J, Qiu J, Wang J, et al. Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis. Front Neurosci. 2019;13:44 pubmed publisher
  13. Zhu Y, Shi C, Bruins L, Wang X, Riggs D, Porter B, et al. Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4. Blood Cancer J. 2019;9:19 pubmed publisher
  14. Haikala H, Anttila J, Marques E, Raatikainen T, Ilander M, Hakanen H, et al. Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy. Nat Commun. 2019;10:620 pubmed publisher
  15. Hu K, Huang Q, Liu C, Li Y, Liu Y, Wang H, et al. c-Jun/Bim Upregulation in Dopaminergic Neurons Promotes Neurodegeneration in the MPTP Mouse Model of Parkinson's Disease. Neuroscience. 2019;399:117-124 pubmed publisher
  16. Pan B, Wu L, Pan L, Yang Y, Li H, Dai Y, et al. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway. Biosci Rep. 2018;38: pubmed publisher
  17. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  18. Mittelstadt P, Taves M, Ashwell J. Cutting Edge: De Novo Glucocorticoid Synthesis by Thymic Epithelial Cells Regulates Antigen-Specific Thymocyte Selection. J Immunol. 2018;200:1988-1994 pubmed publisher
  19. Bogenberger J, Whatcott C, Hansen N, Delman D, Shi C, Kim W, et al. Combined venetoclax and alvocidib in acute myeloid leukemia. Oncotarget. 2017;8:107206-107222 pubmed publisher
  20. Mai W, Gosa L, Daniëls V, Ta L, Tsang J, Higgins B, et al. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med. 2017;23:1342-1351 pubmed publisher
  21. Vu L, Pickering B, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369-1376 pubmed publisher
  22. Jelinek M, Kabelova A, Srámek J, Seitz J, Ojima I, Kovar J. Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells. Anticancer Res. 2017;37:1581-1590 pubmed
  23. Ahmed S, Macara I. The Par3 polarity protein is an exocyst receptor essential for mammary cell survival. Nat Commun. 2017;8:14867 pubmed publisher
  24. Yokoyama T, Kohn E, Brill E, Lee J. Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP. Int J Oncol. 2017;: pubmed publisher
  25. Wang X, Cao W, Zhang J, Yan M, Xu Q, Wu X, et al. A covalently bound inhibitor triggers EZH2 degradation through CHIP-mediated ubiquitination. EMBO J. 2017;36:1243-1260 pubmed publisher
  26. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed publisher
  27. Kong P, Zhu X, Geng Q, Xia L, Sun X, Chen Y, et al. The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer. Mol Ther. 2017;25:1027-1037 pubmed publisher
  28. Mandl M, Zhang S, Ulrich M, Schmoeckel E, Mayr D, Vollmar A, et al. Inhibition of Cdk5 induces cell death of tumor-initiating cells. Br J Cancer. 2017;116:912-922 pubmed publisher
  29. Knudson K, Pritzl C, Saxena V, Altman A, Daniels M, Teixeiro E. NFκB-Pim-1-Eomesodermin axis is critical for maintaining CD8 T-cell memory quality. Proc Natl Acad Sci U S A. 2017;114:E1659-E1667 pubmed publisher
  30. Hsu L, Cheng D, Chen Y, Liang H, Weiss A. Destabilizing the autoinhibitory conformation of Zap70 induces up-regulation of inhibitory receptors and T cell unresponsiveness. J Exp Med. 2017;214:833-849 pubmed publisher
  31. Yang N, Liang Y, Yang P, Yang T, Jiang L. Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression. Braz J Med Biol Res. 2017;50:e5794 pubmed publisher
  32. Laporte A, Barrott J, Yao R, Poulin N, Brodin B, Jones K, et al. HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma. PLoS ONE. 2017;12:e0169407 pubmed publisher
  33. Li Y, Buijs Gladdines J, Cant Barrett K, Stubbs A, Vroegindeweij E, Smits W, et al. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study. PLoS Med. 2016;13:e1002200 pubmed publisher
  34. Suzuki J, Nakajima W, Suzuki H, Asano Y, Tanaka N. Chaperone-mediated autophagy promotes lung cancer cell survival through selective stabilization of the pro-survival protein, MCL1. Biochem Biophys Res Commun. 2017;482:1334-1340 pubmed publisher
  35. Kotschy A, Szlávik Z, Murray J, Davidson J, Maragno A, Le Toumelin Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477-482 pubmed publisher
  36. Wang C, Zhang F, Cao Y, Zhang M, Wang A, Xu M, et al. Etoposide Induces Apoptosis in Activated Human Hepatic Stellate Cells via ER Stress. Sci Rep. 2016;6:34330 pubmed publisher
  37. Wei R, Lin S, Wu W, Chen L, Li C, Chen H, et al. A microtubule inhibitor, ABT-751, induces autophagy and delays apoptosis in Huh-7 cells. Toxicol Appl Pharmacol. 2016;311:88-98 pubmed publisher
  38. Horn T, Ferretti S, Ebel N, Tam A, Ho S, Harbinski F, et al. High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells. Cancer Res. 2016;76:6950-6963 pubmed
  39. Krepler C, Xiao M, Samanta M, Vultur A, Chen H, Brafford P, et al. Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma. Oncotarget. 2016;7:71211-71222 pubmed publisher
  40. Bahr J, Robey R, Luchenko V, Basseville A, Chakraborty A, Kozlowski H, et al. Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras. Oncotarget. 2016;7:69804-69815 pubmed publisher
  41. Ladle B, Li K, Phillips M, Pucsek A, Haile A, Powell J, et al. De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation. Proc Natl Acad Sci U S A. 2016;113:10631-6 pubmed publisher
  42. Pomares H, Palmeri C, Iglesias Serret D, Moncunill Massaguer C, Saura Esteller J, Núñez Vázquez S, et al. Targeting prohibitins induces apoptosis in acute myeloid leukemia cells. Oncotarget. 2016;7:64987-65000 pubmed publisher
  43. Weyhenmeyer B, Noonan J, Würstle M, Lincoln F, Johnston G, Rehm M, et al. Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide. Oncotarget. 2016;7:61295-61311 pubmed publisher
  44. Lai M, Gonzalez Martin A, Cooper A, Oda H, Jin H, Shepherd J, et al. Regulation of B-cell development and tolerance by different members of the miR-17∼92 family microRNAs. Nat Commun. 2016;7:12207 pubmed publisher
  45. Sullivan K, Lewis H, Hill A, Pandey A, Jackson L, Cabral J, et al. Trisomy 21 consistently activates the interferon response. elife. 2016;5: pubmed publisher
  46. Wang C, Ma Y, Hu Q, Xie T, Wu J, Zeng F, et al. Bifidobacterial recombinant thymidine kinase-ganciclovir gene therapy system induces FasL and TNFR2 mediated antitumor apoptosis in solid tumors. BMC Cancer. 2016;16:545 pubmed publisher
  47. Bao H, Liu P, Jiang K, Zhang X, Xie L, Wang Z, et al. Huaier polysaccharide induces apoptosis in hepatocellular carcinoma cells through p38 MAPK. Oncol Lett. 2016;12:1058-1066 pubmed
  48. Liu M, Shan J, Li J, Zhang Y, Lin X. Resveratrol inhibits doxorubicin-induced cardiotoxicity via sirtuin 1 activation in H9c2 cardiomyocytes. Exp Ther Med. 2016;12:1113-1118 pubmed
  49. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  50. Tagscherer K, Fassl A, Sinkovic T, Richter J, Schecher S, Macher Goeppinger S, et al. MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygen. Cancer Cell Int. 2016;16:42 pubmed publisher
  51. Zhao J, Niu X, Li X, Edwards H, Wang G, Wang Y, et al. Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells. Oncotarget. 2016;7:34785-99 pubmed publisher
  52. Hornsveld M, Tenhagen M, van de Ven R, Smits A, van Triest M, van Amersfoort M, et al. Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer. Cell Death Differ. 2016;23:1483-92 pubmed publisher
  53. Matsumoto M, Nakajima W, Seike M, Gemma A, Tanaka N. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells. Biochem Biophys Res Commun. 2016;473:490-6 pubmed publisher
  54. Waldeck K, Cullinane C, Ardley K, Shortt J, Martin B, Tothill R, et al. Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model. Int J Cancer. 2016;139:194-204 pubmed publisher
  55. Yu L, Wu W, Gu C, Zhong D, Zhao X, Kong Y, et al. Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells. Oncotarget. 2016;7:14693-707 pubmed publisher
  56. Stojcheva N, Schechtmann G, Sass S, Roth P, Florea A, Stefanski A, et al. MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM. Oncotarget. 2016;7:12937-50 pubmed publisher
  57. Kline C, van den Heuvel A, Allen J, Prabhu V, Dicker D, El Deiry W. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases. Sci Signal. 2016;9:ra18 pubmed publisher
  58. Wang J, Goetsch L, Tucker L, Zhang Q, Gonzalez A, Vaidya K, et al. Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification. BMC Cancer. 2016;16:105 pubmed publisher
  59. Luo C, Liao W, Dadi S, Toure A, Li M. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature. 2016;529:532-6 pubmed publisher
  60. Lub S, Maes A, Maes K, De Veirman K, De Bruyne E, Menu E, et al. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells. Oncotarget. 2016;7:4062-76 pubmed publisher
  61. Jin H, Gonzalez Martin A, Miletic A, Lai M, Knight S, Sabouri Ghomi M, et al. Transfection of microRNA Mimics Should Be Used with Caution. Front Genet. 2015;6:340 pubmed publisher
  62. Dupont T, Yang S, Patel J, Hatzi K, Malik A, Tam W, et al. Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma. Oncotarget. 2016;7:3520-32 pubmed publisher
  63. Awad K, Elinoff J, Wang S, Gairhe S, Ferreyra G, Cai R, et al. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2016;310:L187-201 pubmed publisher
  64. Nakajima W, Sharma K, Hicks M, Le N, Brown R, Krystal G, et al. Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer. Cancer Biol Ther. 2016;17:27-35 pubmed publisher
  65. Momcilovic M, McMickle R, Abt E, Seki A, Simko S, Magyar C, et al. Heightening Energetic Stress Selectively Targets LKB1-Deficient Non-Small Cell Lung Cancers. Cancer Res. 2015;75:4910-22 pubmed publisher
  66. Ko T, Chin H, Chuah C, Huang J, Ng K, Khaw S, et al. The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia. Oncotarget. 2016;7:2721-33 pubmed publisher
  67. Moncunill Massaguer C, Saura Esteller J, Pérez Perarnau A, Palmeri C, Núñez Vázquez S, Cosialls A, et al. A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation. Oncotarget. 2015;6:41750-65 pubmed publisher
  68. Lauková J, Kozubík A, Hofmanová J, Nekvindová J, Sova P, Moyer M, et al. Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells. PLoS ONE. 2015;10:e0141020 pubmed publisher
  69. Zhang L, Zhang S, Yao J, Lowery F, Zhang Q, Huang W, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 2015;527:100-104 pubmed publisher
  70. Thijssen R, Ter Burg J, van Bochove G, de Rooij M, Kuil A, Jansen M, et al. The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells. Leukemia. 2016;30:337-45 pubmed publisher
  71. Lavik A, Zhong F, Chang M, Greenberg E, Choudhary Y, Smith M, et al. A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2. Oncotarget. 2015;6:27388-402 pubmed publisher
  72. Heinemann A, Cullinane C, De Paoli Iseppi R, Wilmott J, Gunatilake D, Madore J, et al. Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling. Oncotarget. 2015;6:21507-21 pubmed
  73. Dille S, Kleinschnitz E, Kontchou C, Nölke T, Häcker G. In contrast to Chlamydia trachomatis, Waddlia chondrophila grows in human cells without inhibiting apoptosis, fragmenting the Golgi apparatus, or diverting post-Golgi sphingomyelin transport. Infect Immun. 2015;83:3268-80 pubmed publisher
  74. Andersen N, Boguslawski E, Kuk C, Chambers C, Duesbery N. Combined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgrafts. Int J Oncol. 2015;47:71-80 pubmed publisher
  75. Park J, Zhao L, Willingham M, Cheng S. Oncogenic mutations of thyroid hormone receptor β. Oncotarget. 2015;6:8115-31 pubmed
  76. Vogel C, Smit M, Maddalo G, Possik P, Sparidans R, van der Burg S, et al. Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK. Pigment Cell Melanoma Res. 2015;28:307-17 pubmed publisher
  77. Rayavarapu R, Heiden B, Pagani N, Shaw M, Shuff S, Zhang S, et al. The role of multicellular aggregation in the survival of ErbB2-positive breast cancer cells during extracellular matrix detachment. J Biol Chem. 2015;290:8722-33 pubmed publisher
  78. Huang P, Hung S, Pao C, Wang T. N-(1-pyrenyl) maleimide induces bak oligomerization and mitochondrial dysfunction in Jurkat Cells. Biomed Res Int. 2015;2015:798489 pubmed publisher
  79. Van Brocklyn J, Wojton J, Meisen W, Kellough D, Ecsedy J, Kaur B, et al. Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma. Cancer Res. 2014;74:5364-70 pubmed publisher
  80. Eroglu B, Kimbler D, Pang J, Choi J, Moskophidis D, Yanasak N, et al. Therapeutic inducers of the HSP70/HSP110 protect mice against traumatic brain injury. J Neurochem. 2014;130:626-41 pubmed publisher
  81. Nakajima W, Hicks M, Tanaka N, Krystal G, Harada H. Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer. Cell Death Dis. 2014;5:e1052 pubmed publisher
  82. Pavet V, Shlyakhtina Y, He T, Ceschin D, Kohonen P, Perala M, et al. Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells. Cell Death Dis. 2014;5:e1043 pubmed publisher
  83. Crowther A, Gama V, Bevilacqua A, Chang S, Yuan H, Deshmukh M, et al. Tonic activation of Bax primes neural progenitors for rapid apoptosis through a mechanism preserved in medulloblastoma. J Neurosci. 2013;33:18098-108 pubmed publisher
  84. Geissler A, Haun F, Frank D, Wieland K, Simon M, Idzko M, et al. Apoptosis induced by the fungal pathogen gliotoxin requires a triple phosphorylation of Bim by JNK. Cell Death Differ. 2013;20:1317-29 pubmed publisher
  85. Ma T, Galimberti F, Erkmen C, Memoli V, Chinyengetere F, SEMPERE L, et al. Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer. Mol Cancer Ther. 2013;12:1545-55 pubmed publisher
  86. Piazza R, Magistroni V, Mogavero A, Andreoni F, Ambrogio C, Chiarle R, et al. Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex. Neoplasia. 2013;15:511-22 pubmed